Till startsida
University of Gothenburg
Sitemap
To content Read more abput how we use cookies on gu.se

Video Gallery

Re-evaluating an abandoned drug for cancer therapy - The HMBA story

A film by:
Jonas A. Nilsson, professor
Lisa Nilsson senior staff scientist

An old drug candidate, from the 1980s, can help new clinical trials find the right patient category for new cancer drugs. That was the conclusion of a researcher couple at Sahlgrenska Cancer Center, University of Gothenburg, Sweden. By digging through the medical literature they re-discovered a forgotten drug molecule.The findings are described in the article ¿Cancer differentiation agent hexamethylene bisacetamide was likely the first BET bromodomain inhibitor in clinical trials¿ (Nilsson LM et al), published in Cancer Research in¿

Visa filmen i GU Play »

Published 2016-05-27

Video Gallery

tipbox
Page Manager: Veronica Norell|Last update: 5/27/2016
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://cancercenter.gu.se/video/
Utskriftsdatum: 2017-05-25